311 related articles for article (PubMed ID: 22843556)
1. Diabetes and pancreatic cancer.
Cui Y; Andersen DK
Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
[TBL] [Abstract][Full Text] [Related]
2. Pancreatogenic diabetes: special considerations for management.
Cui Y; Andersen DK
Pancreatology; 2011; 11(3):279-94. PubMed ID: 21757968
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and cancer: placing the association in perspective.
Andersen DK
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):81-6. PubMed ID: 23422245
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and cancer.
Vigneri P; Frasca F; Sciacca L; Pandini G; Vigneri R
Endocr Relat Cancer; 2009 Dec; 16(4):1103-23. PubMed ID: 19620249
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic disorders and diabetes mellitus.
Meisterfeld R; Ehehalt F; Saeger HD; Solimena M
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S7-S12. PubMed ID: 18777459
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
10. The complexities of obesity and diabetes with the development and progression of pancreatic cancer.
Bao B; Wang Z; Li Y; Kong D; Ali S; Banerjee S; Ahmad A; Sarkar FH
Biochim Biophys Acta; 2011 Apr; 1815(2):135-46. PubMed ID: 21129444
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
Gallagher EJ; LeRoith D
Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
[TBL] [Abstract][Full Text] [Related]
12. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
13. Metformin and pancreatic cancer: a clue requiring investigation.
Pollak M
Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
[TBL] [Abstract][Full Text] [Related]
14. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
McFarland MS; Cripps R
Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and cancer: a consensus report.
Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?
Ewald N; Bretzel RG
Eur J Intern Med; 2013 Apr; 24(3):203-6. PubMed ID: 23375619
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and pancreatic cancer: chicken or egg?
Magruder JT; Elahi D; Andersen DK
Pancreas; 2011 Apr; 40(3):339-51. PubMed ID: 21412116
[TBL] [Abstract][Full Text] [Related]
20. Cancer risks from diabetes therapies: evaluating the evidence.
Li C; Kong D
Pharmacol Ther; 2014 Oct; 144(1):71-81. PubMed ID: 24844968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
